Even with the limited number of antirheumatic agents available, theoretical considerations lead to an almost infinite number of combination strategies. This article outlines possible strategies based on the primary choice between maximization of efficacy or minimization of toxicity. Strategies are illustrated with examples from trial experience in the field of rheumatoid arthritis.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s002810100073 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!